0 XP   0   0   0

AAREY DRUGS & PHARMACEUTICALS LTD.
Buy, Hold or Sell?

Should you buy, hold or sell AAREY DRUGS & PHARMACEUTICALS LTD.?

I guess you are interested in AAREY DRUGS & PHARMACEUTICALS LTD.. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse AAREY DRUGS & PHARMACEUTICALS LTD.

Let's start. I'm going to help you getting a better view of AAREY DRUGS & PHARMACEUTICALS LTD.. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is AAREY DRUGS & PHARMACEUTICALS LTD. even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how AAREY DRUGS & PHARMACEUTICALS LTD. is doing in the market. If the company is worth buying. The latest step is to find out how other investors value AAREY DRUGS & PHARMACEUTICALS LTD.. The closing price on 2023-01-27 was INR35.05 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
AAREY DRUGS & PHARMACEUTICALS LTD. Daily Candlestick Chart
AAREY DRUGS & PHARMACEUTICALS LTD. Daily Candlestick Chart
Summary









1. Valuation of AAREY DRUGS & PHARMACEUTICALS LTD.




Current price per share

INR35.05

2. Growth of AAREY DRUGS & PHARMACEUTICALS LTD.




Is AAREY DRUGS & PHARMACEUTICALS LTD. growing?

Current yearPrevious yearGrowGrow %
How rich?$13.9m$12.1m$1.8m13.0%

How much money is AAREY DRUGS & PHARMACEUTICALS LTD. making?

Current yearPrevious yearGrowGrow %
Making money$805k$801.2k$3.7k0.5%
Net Profit Margin1.3%1.9%--

How much money comes from the company's main activities?

3. Financial Health of AAREY DRUGS & PHARMACEUTICALS LTD.




Comparing to competitors in the industry




  Industry Rankings ()  



Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

1.1. Profitability of AAREY DRUGS & PHARMACEUTICALS LTD..

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit AAREY DRUGS & PHARMACEUTICALS LTD. earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare AAREY DRUGS & PHARMACEUTICALS LTD. to the  industry mean.
  • A Net Profit Margin of 1.3% means that ₹0.01 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of AAREY DRUGS & PHARMACEUTICALS LTD.:

  • The MRQ is 1.3%. The company is making a profit. +1
  • The TTM is 1.3%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ1.3%TTM1.3%0.0%
TTM1.3%YOY1.9%-0.5%
TTM1.3%5Y1.7%-0.4%
5Y1.7%10Y1.7%0.0%
1.1.2. Return on Assets

Shows how efficient AAREY DRUGS & PHARMACEUTICALS LTD. is using its assets to generate profit.

  • Above 5% is considered healthy but always compare AAREY DRUGS & PHARMACEUTICALS LTD. to the  industry mean.
  • 2.7% Return on Assets means that AAREY DRUGS & PHARMACEUTICALS LTD. generated ₹0.03 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of AAREY DRUGS & PHARMACEUTICALS LTD.:

  • The MRQ is 2.7%. Using its assets, the company is less efficient in making profit.
  • The TTM is 2.7%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ2.7%TTM2.7%0.0%
TTM2.7%YOY2.8%-0.1%
TTM2.7%5Y3.2%-0.6%
5Y3.2%10Y3.2%0.0%
1.1.3. Return on Equity

Shows how efficient AAREY DRUGS & PHARMACEUTICALS LTD. is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare AAREY DRUGS & PHARMACEUTICALS LTD. to the  industry mean.
  • 5.8% Return on Equity means AAREY DRUGS & PHARMACEUTICALS LTD. generated ₹0.06 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of AAREY DRUGS & PHARMACEUTICALS LTD.:

  • The MRQ is 5.8%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 5.8%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ5.8%TTM5.8%0.0%
TTM5.8%YOY6.6%-0.8%
TTM5.8%5Y6.5%-0.8%
5Y6.5%10Y6.5%0.0%

1.2. Operating Efficiency of AAREY DRUGS & PHARMACEUTICALS LTD..

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient AAREY DRUGS & PHARMACEUTICALS LTD. is operating .

  • Measures how much profit AAREY DRUGS & PHARMACEUTICALS LTD. makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare AAREY DRUGS & PHARMACEUTICALS LTD. to the  industry mean.
  • An Operating Margin of 0.0% means the company generated ₹0.00  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of AAREY DRUGS & PHARMACEUTICALS LTD.:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y0.8%-0.8%
5Y0.8%10Y0.8%0.0%
1.2.2. Operating Ratio

Measures how efficient AAREY DRUGS & PHARMACEUTICALS LTD. is keeping operating costs low.

  • Below 1 is considered healthy (always compare to  industry mean).
  • An Operation Ratio of 1.94 means that the operating costs are ₹1.94 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of AAREY DRUGS & PHARMACEUTICALS LTD.:

  • The MRQ is 1.941. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.941. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.941TTM1.9410.000
TTM1.941YOY1.960-0.019
TTM1.9415Y1.951-0.010
5Y1.95110Y1.9510.000

1.3. Liquidity of AAREY DRUGS & PHARMACEUTICALS LTD..

1.3. Liquidity
1.3.1. Current Ratio

Measures if AAREY DRUGS & PHARMACEUTICALS LTD. is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to  industry mean).
  • A Current Ratio of 1.74 means the company has ₹1.74 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of AAREY DRUGS & PHARMACEUTICALS LTD.:

  • The MRQ is 1.740. The company is able to pay all its short-term debts. +1
  • The TTM is 1.740. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.740TTM1.7400.000
TTM1.740YOY1.647+0.093
TTM1.7405Y1.876-0.136
5Y1.87610Y1.8760.000
1.3.2. Quick Ratio

Measures if AAREY DRUGS & PHARMACEUTICALS LTD. is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare AAREY DRUGS & PHARMACEUTICALS LTD. to the  industry mean.
  • A Quick Ratio of 1.11 means the company can pay off ₹1.11 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of AAREY DRUGS & PHARMACEUTICALS LTD.:

  • The MRQ is 1.105. The company is just able to pay all its short-term debts with the most liquid assets.
  • The TTM is 1.105. The company is just able to pay all its short-term debts with the most liquid assets.
Trends
Current periodCompared to+/- 
MRQ1.105TTM1.1050.000
TTM1.105YOY1.222-0.116
TTM1.1055Y1.294-0.189
5Y1.29410Y1.2940.000

1.4. Solvency of AAREY DRUGS & PHARMACEUTICALS LTD..

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of AAREY DRUGS & PHARMACEUTICALS LTD. assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare AAREY DRUGS & PHARMACEUTICALS LTD. to industry mean.
  • A Debt to Asset Ratio of 0.54 means that AAREY DRUGS & PHARMACEUTICALS LTD. assets are financed with 53.6% credit (debt) and the remaining percentage (100% - 53.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of AAREY DRUGS & PHARMACEUTICALS LTD.:

  • The MRQ is 0.536. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.536. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.536TTM0.5360.000
TTM0.536YOY0.576-0.039
TTM0.5365Y0.511+0.026
5Y0.51110Y0.5110.000
1.4.2. Debt to Equity Ratio

Measures if AAREY DRUGS & PHARMACEUTICALS LTD. is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare AAREY DRUGS & PHARMACEUTICALS LTD. to the  industry mean.
  • A Debt to Equity ratio of 115.7% means that company has ₹1.16 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of AAREY DRUGS & PHARMACEUTICALS LTD.:

  • The MRQ is 1.157. The company is able to pay all its debts with equity. +1
  • The TTM is 1.157. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ1.157TTM1.1570.000
TTM1.157YOY1.357-0.200
TTM1.1575Y1.075+0.082
5Y1.07510Y1.0750.000

2. Market Valuation of AAREY DRUGS & PHARMACEUTICALS LTD.

2. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings AAREY DRUGS & PHARMACEUTICALS LTD. generates.

  • Above 15 is considered overpriced but always compare AAREY DRUGS & PHARMACEUTICALS LTD. to the  industry mean.
  • A PE ratio of 16.06 means the investor is paying ₹16.06 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of AAREY DRUGS & PHARMACEUTICALS LTD.:

  • The EOD is 13.595. Very good. +2
  • The MRQ is 16.057. Very good. +2
  • The TTM is 16.057. Very good. +2
Trends
Current periodCompared to+/- 
EOD13.595MRQ16.057-2.463
MRQ16.057TTM16.0570.000
TTM16.057YOY8.328+7.729
TTM16.0575Y10.021+6.036
5Y10.02110Y10.0210.000
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of AAREY DRUGS & PHARMACEUTICALS LTD..

  • Lower is better.
  • A PEG ratio of 1 means the market price of the stock and the expected future earnings are on par.

Let's take a look of the Price Earnings to Growth Ratio trends of AAREY DRUGS & PHARMACEUTICALS LTD.:

  • The MRQ is 17.350. Seems overpriced? -1
  • The TTM is 17.350. Seems overpriced? -1
Trends
Current periodCompared to+/- 
MRQ17.350TTM17.3500.000
TTM17.350YOY7.407+9.943
TTM17.3505Y10.273+7.077
5Y10.27310Y10.2730.000

2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of AAREY DRUGS & PHARMACEUTICALS LTD. is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to industry mean).
  • A PB ratio of 0.92 means the investor is paying ₹0.92 for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of AAREY DRUGS & PHARMACEUTICALS LTD.:

  • The EOD is 0.783. Very good. +2
  • The MRQ is 0.925. Very good. +2
  • The TTM is 0.925. Very good. +2
Trends
Current periodCompared to+/- 
EOD0.783MRQ0.925-0.142
MRQ0.925TTM0.9250.000
TTM0.925YOY0.549+0.376
TTM0.9255Y0.648+0.277
5Y0.64810Y0.6480.000
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of AAREY DRUGS & PHARMACEUTICALS LTD. compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--2.4902.4900%2.786-11%11.192-78%11.192-78%
Book Value Growth--1.1491.1490%1.071+7%1.096+5%1.096+5%
Book Value Per Share--44.76644.7660%42.276+6%40.886+9%40.886+9%
Book Value Per Share Growth--1.0591.0590%1.071-1%1.065-1%1.065-1%
Current Ratio--1.7401.7400%1.647+6%1.876-7%1.876-7%
Debt To Asset Ratio--0.5360.5360%0.576-7%0.511+5%0.511+5%
Debt To Equity Ratio--1.1571.1570%1.357-15%1.075+8%1.075+8%
Dividend Per Share----0%-0%0.025-100%0.025-100%
Eps--2.5782.5780%2.786-7%2.660-3%2.660-3%
Eps Growth--0.9260.9260%1.124-18%0.979-5%0.979-5%
Free Cash Flow Per Share---2.637-2.6370%1.111-337%-0.232-91%-0.232-91%
Free Cash Flow Per Share Growth---2.374-2.3740%1.340-277%1.520-256%1.520-256%
Free Cash Flow To Equity Per Share---2.637-2.6370%1.111-337%-0.497-81%-0.497-81%
Free Cash Flow To Equity Per Share Growth---2.374-2.3740%1.340-277%0.536-543%0.536-543%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Net Profit Margin--0.0130.0130%0.019-29%0.017-24%0.017-24%
Operating Margin----0%-0%0.008-100%0.008-100%
Operating Ratio--1.9411.9410%1.960-1%1.9510%1.9510%
Pb Ratio0.783-18%0.9250.9250%0.549+69%0.648+43%0.648+43%
Pe Ratio13.595-18%16.05716.0570%8.328+93%10.021+60%10.021+60%
Peg Ratio--17.35017.3500%7.407+134%10.273+69%10.273+69%
Price Per Share35.050-18%41.40041.4000%23.200+78%26.700+55%26.700+55%
Price To Total Gains Ratio14.074-18%16.62416.6240%8.328+100%7.775+114%7.775+114%
Profit Growth--1.0051.0050%1.124-11%1.0050%1.0050%
Quick Ratio--1.1051.1050%1.222-10%1.294-15%1.294-15%
Return On Assets--0.0270.0270%0.028-5%0.032-17%0.032-17%
Return On Equity--0.0580.0580%0.066-13%0.065-12%0.065-12%
Revenue Growth--1.4131.4130%1.159+22%1.139+24%1.139+24%
Total Gains Per Share--2.4902.4900%2.786-11%11.217-78%11.217-78%
Total Gains Per Share Growth--0.8940.8940%1.124-20%0.695+29%0.695+29%
Usd Book Value--13977382.83213977382.8320%12159836.814+15%12035442.064+16%12035442.064+16%
Usd Book Value Change Per Share--0.0310.0310%0.034-11%0.138-78%0.138-78%
Usd Book Value Per Share--0.5510.5510%0.520+6%0.503+9%0.503+9%
Usd Dividend Per Share----0%-0%0.000-100%0.000-100%
Usd Eps--0.0320.0320%0.034-7%0.033-3%0.033-3%
Usd Free Cash Flow---823402.479-823402.4790%319517.260-358%-82944.018-90%-82944.018-90%
Usd Free Cash Flow Per Share---0.032-0.0320%0.014-337%-0.003-91%-0.003-91%
Usd Free Cash Flow To Equity Per Share---0.032-0.0320%0.014-337%-0.006-81%-0.006-81%
Usd Price Per Share0.431-18%0.5090.5090%0.285+78%0.328+55%0.328+55%
Usd Profit--805010.006805010.0060%801259.638+0%780878.037+3%780878.037+3%
Usd Revenue--60467991.09560467991.0950%42790283.913+41%45949484.280+32%45949484.280+32%
Usd Total Gains Per Share--0.0310.0310%0.034-11%0.138-78%0.138-78%
 EOD+3 -2MRQTTM+0 -0YOY+13 -255Y+11 -3010Y+11 -30

3.2. Fundamental Score

Let's check the fundamental score of AAREY DRUGS & PHARMACEUTICALS LTD. based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1513.595
Price to Book Ratio (EOD)Between0-10.783
Net Profit Margin (MRQ)Greater than00.013
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than11.105
Current Ratio (MRQ)Greater than11.740
Debt to Asset Ratio (MRQ)Less than10.536
Debt to Equity Ratio (MRQ)Less than11.157
Return on Equity (MRQ)Greater than0.150.058
Return on Assets (MRQ)Greater than0.050.027
Total6/10 (60.0%)

3.3. Technical Score

Let's check the technical score of AAREY DRUGS & PHARMACEUTICALS LTD. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose35.750
Total1/1 (100.0%)



Latest Balance Sheet

Balance Sheet of 2022-03-31. Currency in INR. All numbers in thousands.

Summary
Total Assets2,451,688
Total Liabilities1,315,316
Total Stockholder Equity1,136,373
 As reported
Total Liabilities 1,315,316
Total Stockholder Equity+ 1,136,373
Total Assets = 2,451,688

Assets

Total Assets2,451,688
Total Current Assets2,263,236
Long-term Assets2,263,236
Total Current Assets
Cash And Cash Equivalents 1,919
Short-term Investments 75,068
Net Receivables 1,362,830
Inventory 136,839
Other Current Assets 643
Total Current Assets  (as reported)2,263,236
Total Current Assets  (calculated)1,577,299
+/- 685,937
Long-term Assets
Long-term Assets  (as reported)188,452
Long-term Assets  (calculated)0
+/- 188,452

Liabilities & Shareholders' Equity

Total Current Liabilities1,300,762
Long-term Liabilities14,554
Total Stockholder Equity1,136,373
Total Current Liabilities
Short Long Term Debt 141,625
Accounts payable 1,096,615
Other Current Liabilities 10,212
Total Current Liabilities  (as reported)1,300,762
Total Current Liabilities  (calculated)1,248,452
+/- 52,310
Long-term Liabilities
Long-term Liabilities Other 0
Long-term Liabilities  (as reported)14,554
Long-term Liabilities  (calculated)0
+/- 14,554
Total Stockholder Equity
Retained Earnings 446,534
Total Stockholder Equity (as reported)1,136,373
Total Stockholder Equity (calculated)446,534
+/- 689,839
Other
Capital Stock253,847
Common Stock Shares Outstanding 25,385
Net Debt 139,706
Net Invested Capital 1,277,997
Net Working Capital 962,475



Balance Sheet

Currency in INR. All numbers in thousands.

 Trend2022-03-312021-03-312020-03-312019-03-312018-03-312017-03-31
> Total Assets 
0
0
1,457,154
1,940,832
2,330,357
2,451,688
2,451,6882,330,3571,940,8321,457,15400
   > Total Current Assets 
1,298,833
1,572,886
1,329,924
1,813,440
2,183,775
2,263,236
2,263,2362,183,7751,813,4401,329,9241,572,8861,298,833
       Cash And Cash Equivalents 
0
0
3,455
4,873
6,367
1,919
1,9196,3674,8733,45500
       Short-term Investments 
0
0
233
154
130
75,068
75,06813015423300
       Net Receivables 
818,566
952,972
1,089,833
961,333
1,620,123
1,362,830
1,362,8301,620,123961,3331,089,833952,972818,566
       Inventory 
450,161
536,598
212,504
169,960
184,606
136,839
136,839184,606169,960212,504536,598450,161
       Other Current Assets 
19,726
49,418
23,901
630,687
264
643
643264630,68723,90149,41819,726
   > Long-term Assets 
0
0
127,230
127,393
146,581
188,452
188,452146,581127,393127,23000
       Property Plant Equipment 
121,455
120,548
122,746
122,993
0
0
00122,993122,746120,548121,455
> Total Liabilities 
0
0
591,628
1,017,371
1,341,752
1,315,316
1,315,3161,341,7521,017,371591,62800
   > Total Current Liabilities 
916,992
881,932
576,324
1,002,778
1,326,120
1,300,762
1,300,7621,326,1201,002,778576,324881,932916,992
       Short Long Term Debt 
0
0
161,164
178,684
180,172
141,625
141,625180,172178,684161,16400
       Accounts payable 
730,680
759,373
372,785
777,497
1,103,399
1,096,615
1,096,6151,103,399777,497372,785759,373730,680
       Other Current Liabilities 
66,757
72,840
39,569
46,597
0
10,212
10,212046,59739,56972,84066,757
   > Long-term Liabilities 
0
0
15,304
14,593
15,632
14,554
14,55415,63214,59315,30400
       Long-term Liabilities Other 
0
0
0
0
20
0
0200000
> Total Stockholder Equity
0
0
865,526
923,462
988,605
1,136,373
1,136,373988,605923,462865,52600
   Retained Earnings 
133,152
194,928
258,007
315,943
381,086
446,534
446,534381,086315,943258,007194,928133,152
   Accumulated Other Comprehensive Income 000000
   Capital Surplus 000000
   Treasury Stock000000



Balance Sheet

Currency in INR. All numbers in thousands.




Cash Flow

Currency in INR. All numbers in thousands.




Income Statement

Currency in INR. All numbers in thousands.


Latest Income Statement (annual, 2022-03-31)

Gross Profit (+$)
totalRevenue4,916,097
Cost of Revenue-4,720,649
Gross Profit195,447195,447
 
Operating Income (+$)
Gross Profit195,447
Operating Expense-4,821,516
Operating Income94,581-4,626,069
 
Operating Expense (+$)
Research Development-
Selling General Administrative10,028
Selling And Marketing Expenses-
Operating Expense4,821,51610,028
 
Net Interest Income (+$)
Interest Income20,086
Interest Expense-19,123
Net Interest Income-310964
 
Pretax Income (+$)
Operating Income94,581
Net Interest Income-310
Other Non-Operating Income Expenses-
Income Before Tax (EBT)100,27194,581
EBIT - interestExpense = -19,123
65,448
84,571
Interest Expense19,123
Earnings Before Interest and Taxes (ebit)-119,393
Earnings Before Interest and Taxes (ebitda)139,276
 
After tax Income (+$)
Income Before Tax100,271
Tax Provision-34,823
Net Income From Continuing Ops65,44865,448
Net Income65,448
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-310
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
NGU24-NYM.COMM
6 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of NGU24-NYM.COMM.

NGU24-NYM.COMM Daily Candlestick Chart
NGM24-NYM.COMM
6 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of NGM24-NYM.COMM.

NGM24-NYM.COMM Daily Candlestick Chart
NGQ24-NYM.COMM
6 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of NGQ24-NYM.COMM.

NGQ24-NYM.COMM Daily Candlestick Chart
ISKJ.MCX
6 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of ISKJ.MCX.

ISKJ.MCX Daily Candlestick Chart
CHKZ.MCX
6 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of CHKZ.MCX.

CHKZ.MCX Daily Candlestick Chart
VSYD.MCX
6 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of VSYD.MCX.

VSYD.MCX Daily Candlestick Chart
VRSB.MCX
6 hours ago

I found you a Golden Cross on the daily chart of VRSB.MCX.

VRSB.MCX Daily Candlestick Chart
TBRU.MCX
6 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of TBRU.MCX.

TBRU.MCX Daily Candlestick Chart
SNGSP.MCX
6 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of SNGSP.MCX.

SNGSP.MCX Daily Candlestick Chart
RBCM.MCX
6 hours ago

I found you a Golden Cross on the daily chart of RBCM.MCX.

RBCM.MCX Daily Candlestick Chart
OKEY.MCX
6 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of OKEY.MCX.

OKEY.MCX Daily Candlestick Chart
MTLR.MCX
6 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of MTLR.MCX.

MTLR.MCX Daily Candlestick Chart
MRKZ.MCX
6 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of MRKZ.MCX.

MRKZ.MCX Daily Candlestick Chart
KRKN.MCX
6 hours ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of KRKN.MCX.

KRKN.MCX Daily Candlestick Chart
JNOS.MCX
6 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of JNOS.MCX.

JNOS.MCX Daily Candlestick Chart
BLNG.MCX
6 hours ago

I found you a Golden Cross on the daily chart of BLNG.MCX.

BLNG.MCX Daily Candlestick Chart
ASSB.MCX
6 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of ASSB.MCX.

ASSB.MCX Daily Candlestick Chart
CSYZ.MU
6 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of CSYZ.MU.

CSYZ.MU Daily Candlestick Chart
MOH.MU
6 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of MOH.MU.

MOH.MU Daily Candlestick Chart
TBK.V
6 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of TBK.V.

TBK.V Daily Candlestick Chart
UMDK.F
6 hours ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of UMDK.F.

UMDK.F Daily Candlestick Chart
RY4C.BE
6 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of RY4C.BE.

RY4C.BE Daily Candlestick Chart
PLY.BE
6 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of PLY.BE.

PLY.BE Daily Candlestick Chart
PDL.LSE
6 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of PDL.LSE.

PDL.LSE Daily Candlestick Chart
27F0.MU
6 hours ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of 27F0.MU.

27F0.MU Daily Candlestick Chart